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Summary
The aim of the present study was to examine if dietary
inclusion of vegetable lipids (VL) and proteins (VP) influenced
markers of bone health in Atlantic salmon. Triplicate groups
were fed one of four different diets; 100% fish protein (FP) and
fish lipids (FL) (FPFL), 80% VP and 35% VL (80VP35VL),
40% VP and 70% VL (40VP70VL), or 80% VP and 70% VL
(80VP70VL) for 12 months on-growth in sea water. Fish were
analyzed for vertebral bone mineralization (mineral content, as
% of bone dry weight), vertebral deformities (radiology),
vertebral bone mRNA expression of factors involved in
mineralization (bone gla protein, bgp) and growth regulation
(igf-I and growth hormone receptor), as well as plasma vitamin
D metabolites. The fish grew from 0.35 to 4 kg during the
experimental period. At the end of the experiment, signifi-
cantly lower prevalence of fish with one or more deformed
vertebrae was observed in the 80VP70VL group (11%)
compared to the other groups (33–43%). There was a
significant higher relative expression of igf-I mRNA in
vertebral bone of fish fed the 80VP70VL diet compared to
control fish (FPFL), while the other genes studied were
unaffected. Elevated plasma 25-hydroxyvitamin D3 recorded
in the marine feed group is discussed as a predictor for later
development of bone deformities. In conclusion, the present
study shows that high inclusion levels of vegetable lipids and
proteins may have a positive effect on bone health in Atlantic
salmon postsmolts.
Introduction
Marine feed resources are a limiting factor for further
expansion of the salmon farming industry and it is essential
that new feed resources become available (Tacon, 2004; Pike,
2005). Vegetable protein (Espe et al., 2006) and lipid (Tor-
stensen et al., 2005) sources are therefore being included into
salmon diets at an increasing rate. At present, the main
challenges of these replacements have been the low marine
polyunsaturated fatty acid composition (Menoyo et al., 2007;
Bell and Waagbø, 2008), unbalanced essential amino acid
composition (NRC, 1993; Halver and Hardy, 2002), and high
levels of antinutrients (Francis et al., 2001) in such diets. The
impact of vegetable feed ingredients on growth (Waagbø et al.,
1991; Torstensen et al., 2000, 2005; Mundheim et al., 2004;
Espe et al., 2006; Pratoomyot et al., 2008), feed utilization
(Opstvedt et al., 2003), and product quality (Waagbø et al.,
1993; Mundheim et al., 2004; Torstensen et al., 2005; Menoyo
et al., 2007), has been extensively studied in Atlantic salmon.
There has also been some work on fish health (Oxley et al.,
2005; Seierstad et al., 2005, 2009; Waagbø, 2006, 2008; Hemre
and Sandnes, 2008). However, the knowledge on the impact of
plant ingredient based diets on fish health and welfare is still
limited, especially on bone health aspects such as mineraliza-
tion and development of bone anomalies. Vertebral deformi-
ties is a common problem in salmon farming (Waagbø et al.,
2005; Witten et al., 2005; Fjelldal et al., 2007a; Sullivan et al.,
2007a; Waagbø, 2008), where it results in down-grading losses
during harvest (Michie, 2001) and constitutes an ethical
dilemma related to fish welfare (Hansen et al., 2010; Fjelldal,
P.G., Yurtseva, A.,Berg, A., 2009, Unpubl. data).
The present experiment was designed to study the impact of
vegetable feed ingredients on the development of vertebral
deformities in Atlantic salmon, during an 1 year on-growth
period in seawater. Triplicate groups of salmon were fed
complete diets; a normal marine diet, or diets with three
different inclusion levels of vegetable lipids and proteins. Gene
expressional levels in vertebral bone of bone gla protein (also
named osteocalcin, bgp), igf-I and growth hormone receptor,
and vertebral bone mineral content was monitored to assay
possible effects on bone physiology. Finally, plasma vitamin D
metabolites was examined in fish fed the marine diet and the
complete vegetable diet, since these dietary groups represents a
dramatic change in vitamin D supply, and since changes in the
vitamin endocrine system previously has been related to
development of bone deformities (Fjelldal et al., 2009).
Material and method
Fish stock, rearing conditions, and experimental design
Triplicate groups of Atlantic salmon postsmolts (355 g) were
fed one of four different diets; 100% fish protein and lipid
(FPFL), 80% vegetable protein (VP) and 35% vegetable lipid
(VL) (80VP35VL), 40% VP and 70% VL (40VP70VL), or
80% VP and 70% VL (80VP70VL) for 12 months in sea water
tanks (volume: 12–10 m3, salinity: 34.9 g L)1, water supply:
52 L min)1). Each tank contained 500 fish (strain: AkvaGen
AS, Tingvoll, Norway) at the start of the experiment (1500 fish
per dietary group), the temperature was stable at 8.9 ± 0.1C
throughout the study, and the oxygen saturation of the outlet
water was never < 80%. For a detailed description of the fish
stock, rearing conditions, experimental design and diet com-
position see Torstensen et al. (2008).
In Feb, after 8 months of exposure to the experimental diets,
part of the population from the marine control group (FPFL;
previously marked by fin marking) and the vegetable group
(80VP70VL) were exchanged between respective triplicates
(crossed-over), to examine short- term responses to changes in
diet. A sampling conducted 1 month (27 days) therafter of
theses groups, included analysis of plasma vitamin D metab-
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olites [25OHD3 and 1,25(OH)2D3], as well as plasma calcium
and phosphorous.
Sampling
Whole vertebral columns were dissected and prepared for
radiology at the start of the experiment in June 2006 (n = 30,
random sample of 30 fish before the start of the experiment),
and in Nov 2006 (n = 120; 30 per dietary group) and June
2007 (n = 150; 30 in the 80VP35VL and 40VP70VL groups
and 45 in the FPFL and 80VP70VL groups). Vertebrae
number 43 was dissected for RNA extraction (n = 18; 9 per
dietary group) in July 2006 and June 2007, and for measure-
ment of mineral content (n = 60; 30 per dietary group) in June
2007 from the FPFL and 80VP70VL dietary groups.
Radiology
Dissected vertebral columns were radiographed by using a
portable X-ray apparatus (HI-Ray 100, Eickenmeyer Medi-
zintechnik fu¨r Tiera¨rzte e.K., Tuttlingen, Germany) and
30 · 40 cm film (FUJIFILM IX 100, FUJIFILM Corp.,
Tokyo, Japan). The film was exposed for 50 mAs and 72 kV
(90 cm), developed using a manual developer (Cofar Cemat
C56D, Arcore (MI), Italy) with Kodak Professional manual
fixer and developer (KODAK S.A., Paris, France), and
digitalised by scanning (Epson Expression 10000 XL, Seiko
Epson Corp., Nagano-Ken, Japan). Each fish were evaluated
for vertebral deformities, and the location and type of
deformity was recorded according to Fjelldal et al. (2007a).
Mineral content
Vertebrae number 43 were defatted in acetone and chloroform
baths, dried overnight at 100C, and then incinerated for
13.5 h in a muffle furnace (Mod. L40, Nabertherm GmbH,
Bremen, Germany) (115C for 0.5 h, 540C for 5 h, and 750C
for 8 h). The dry and ash (mineral) weights of each individual
were weighed to nearest 10)2 mg. The mineral content was
calculated as follow:
Mineral content ¼ ðmineral weightÞ ðdry weightÞ1
RNA isolation and RT-PCR
After dissection, samples were immediately frozen on liquid
nitrogen. Total RNA were extracted from each sample using
the FastRNA Pro Green Kit (Qbiogene). RNA used for
RT-PCR was DNAse treated according to manufactures
recommendations (Invitrogen). The amount and quality of
was verified by the Nanodrop ND-1000 spectrophotometer
(NanoDrop Technologies, USA). All gene expressional level
analysis reactions were run on the 7900 HT Fast Real-Time
PCR system. The PCR conditions was 50C for 2 min
followed by 95C for 10 min, the reactions thereafter pro-
ceeded through 40 cycles of 95C for 15 s followed by 60C for
1 min. Primers used for the real-time analysis are shown in
Table 1. The efficiency of targets in relation to reference [ela
(Olsvik et al., 2005)] was determined using a standard curve
method together with a validation experiment (ABI User
Bulletin #2 for ABI 7700 sequence detections system). In the
validation experiment 500, 250, 125, 62.5 and 31.1 ng of RNA
was used for cDNA synthesis and the slope of log input
amount of RNA vs delta Ct is included in Table 1. All genes
used displayed approximately equal efficiency between target
and reference. The relative expression level was calculated
using the Comparative Ct method (ABI User Bulletin #2 for
ABI 7700 sequence detection system). In all experiments no-
template controls and standard curve were run together with
the samples.
Plasma vitamin D metabolite analysis, calcium and phoshorous
The vitamin D metabolites, 25-hydroxyvitamin D3 (25OHD3)
and 1,25-dihydroxyvitamin D3 [1,25(OH)2D3; calcitriol] were
analysed by use of liquid chromatography-tandem mass
spectroscopy according to a modified method (Fjelldal et al.,
2009), based on (Kissmeyer et al., 2000; Kissmeyer and Sonne,
2001). The UPLC ⁄ MS ⁄ MS system (Waters, Milford, MA,
USA) and running conditions are described by Fjelldal et al.
(2009). Plasma samples were protein precipitated, solid phase
(Isolute MF C18 SPE cartridge) extracted and eluted with
heptan:2-propanol (93:7), evaporated under N2, and finally
reconstituted in 200 ll methanol : 1 M ammonium ace-
tate:water (500:2:500) before injected into the LC system.
External calibration curves (ranging from 0.6 to 24 nmol L)1)
were applied based upon standard solutions of the two
metabolites treated in the same way as the samples, while a
similar amount of deuterised 25OHD3 was used as internal
standard in all samples and standards. An in-house fish plasma
was used in the quality control.
Statistics
Data were analysed using Statistica (version 8.0, Statsoft,
Tulsa, USA). Significant differences in gene expressional levels
were tested with a two-way ANOVA with diet and time as the
dependent factors. Significant ANOVAs were followed by
Bonferronis multiple comparison test to locate any differences
between diets or over time. Significant differences in vertebral
Table 1
Relative gene expression (mean±SE) in vertebral bone of bgp, igf-I, and ghr in Atlantic salmon fed a 100% fish protein and lipid diet (FPFL;
n = 18, 9 per date) or a replacement diet with 80% vegetable protein and 70% vegetable lipid (80VP70LP; n = 18, 9 per date) for 1 year in
seawater (June 2006 to June 2007)
Parameter
FPFL1 80VP70VL1 P-value
July 06 June 07 July 06 June 07 Date Diet
bgp 0.82 ± 0.16 1.07 ± 0.19 0.60 ± 0.12 1.02 ± 0.13 0.036 0.374
Igf-I 1.52 ± 0.18ab 0.94 ± 0.13b 1.93 ± 0.12a 1.24 ± 0.23b 0.0006 0.039
ghr 2.58 ± 0.39a 0.88 ± 0.12c 2.04 ± 0.29ab 1.03 ± 0.06bc 0.000007 0.451
1Different lower case letters indicate significant differences (Bonferronis test, P < 0.05) within a parameter with a as the highest value.
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bone mineral content between diets were tested with a one-way
ANOVA. Chi-square tests were used to test dietary group
differences in the prevalence of deformed fish within sampling
points (level of significance Bonferroni adjusted to
P < 0.0125, Sokal and Rohlf, 1995). Differences in vitamin
D metabolites were tested by use of a nested ANOVA (fish nested
in tanks) and Tukeys post hoc test.
Results
Mortality
Mortality was negligible (< 1%) in all dietary groups during
the entire experimental period (Torstensen et al., 2008).
Somatic growth
For details on somatic growth, see Torstensen et al. (2008).
The group fed the highest inclusion level of vegetable proteins
and lipids grew slower (SGR, % day)1) compared to the other
groups during the first 3 months of the experiment (June–
September 2006), while the growth rate was equal between the
groups during the rest of the experiment.
Vertebral bone mineralization and gene expression
The expressional level of igf-I in vertebral bone was signif-
icantly higher (two-way ANOVA, P < 0.05) in the fish fed the
80VP70VL diet compared to the fish fed the FPFL diet
(Table 1). There were no dietary effects on the other studied
genes. However, there was a significant effect (two-way ANOVA,
P < 0.05) of date on the expressional levels of bgp, igf-I and
ghr in vertebral bone, with significantly higher (Bonferronis
test, P < 0.05) levels of igf-I in July 2006 compared to June
2007 in the fish fed the 80VP70VL diet, and of ghr in July 2006
compared to June 2007 in the fish fed the FPFL diet (Table 1).
Mean (±SE) mineral content in the bone of the vertebrae in
June 2007 was not significantly different (one-way ANOVA,
P = 0.1) between the marine control diet (57.2% ± 0.12,
n = 30) and the high vegetable inclusion diet (57.4% ± 0.10,
n = 30).
Vertebral deformities
In June 2007, there was a significant lower prevalence (Chi-
square, P < 0.0125) of fish with one or more deformed
vertebrae in the high vegetable inclusion diet 80VP70VL
compared to the other diets (Table 2). The prevalence of
deformed vertebrae in the deformed fish was not significantly
different (one-way ANOVA, P > 0.05) between groups (pooled
mean 6.5% ± 0.9 S.E., n = 45). However, there was a
tendency to less severely deformed fish in the high vegetable
inclusion diet compared to the other diets (Table 2). There
were no increase over time in the prevalence of fish with one or
more deformed vertebrae in the 80VP70VL group, while the
other groups showed an increase in this parameter (Fig. 1).
The predominate location for vertebral deformities at the
termination of the experiment in June 2007 was in the most
cranial and caudal parts of the vertebral column (Fig. 2,
radiographic example in Fig. 3a,b), and 67% of the deformed
vertebrae suffered from ankylosis and compression, while 33%
were compressed.
Vitamin D metabolites
Plasma 25OHD3 and 1,25(OH)2D3 were analysed in the
marine control and the high vegetable dietary groups in Feb
2007, 1 month after change in diet (cross-over). Fish contious-
ly fed on the marine control diet showed significantly elevated
plasma 25OHD3 concentrations compared to fish contiously
fed the vegetable diet (Fig. 4). Fish crossed-over from the
marine to vegetable diet reduced the plasma 25OHD3 concen-
trations to vegetable diet level during the 27 days, while vica
Table 2
Number (n) of radiographed fish and of fish with one or more deformed vertebrae (V), 1-2 deformed V, 3-10 deformed V and 11-18 deformed V at
the end of the experiment in June 2007 in Atlantic salmon fed diets containing 100% fish protein and lipid (FPFL), 80% vegetable protein (VP)
and 35% vegetable lipid (VL) (80VP35VL), 40% VP and 70% VL (40VP70VL), or 80% VP and 70% VL (80VP70VL) for 12 months in sea water
Category
Diet1
FPFL (n) 80VP35VL (n) 40VP70VL (n) 80VP70VL (n)
Analysed fish 45 30 30 45
Fish with ‡ 1 deformed vertebrae 15 (33%)a 13 (43%)a 12 (40%)a 5 (11%)b
1–2 deformed vertebrae 6 8 6 4
3–10 deformed vertebrae 8 4 5 1
11–18 deformed vertebrae 1 1 1
1Different lower case letters indicate significant differences (Chi square, P < 0.0125) within a category with a as the highest value.
Fig. 1. Changes in prevalence (%) of one or more deformed vertebrae
in Atlantic salmon evolving during the experimental period when
reared for 12 months in sea water and fed diets containing 100% fish
protein and lipid (FPFL), 80% vegetable protein (VP) and 35%
vegetable lipid (VL) (80VP35VL), 40% VP and 70% VL (40VP70VL),
or 80% VP and 70% VL (80VP70VL). The values are means ± SE
(bars) of three replicate tanks per treatment
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versa crossed-over fish did not increase vitamin D status. For
the active vitamin D metabolite plasma 1,25(OH)2D3, no
significant differences were observed between the dietary
groups (Fig. 4).
Discussion
The results of the present study clearly demonstrated that a
high inclusion level of vegetable proteins and lipids had no
negative effects on the recorded bone health parameters in
Atlantic salmon postsmolts, since the prevalence of vertebral
deformities was stable over time and lowest at the termination
of the experiment in the fish fed the high vegetable
(80VP70VL) diet, and there were no significant effects on
bone mineralization of the different diets.
The prevalence of vertebral deformities
The prevalence of deformed fish increased from 13% to 33–
43% during the experimental period in the FPFL, 80VP35VL
and 40VP70VL diets, while it was stable over time and ranged
between 11 and 16% in the 80VP70VL diet. Other studies have
shown an increase over time in the prevalence of vertebral
deformities during on-growth in seawater (Fjelldal et al.,
2007a, 2009), and Fjelldal et al. (2009) found that salmon
fed a diet (approximately 20VP50VL) with extra mineral
supply during the first period in seawater had a prevalence of
deformed fish of 15% at transfer to seawater, and 36% 1 year
later, based on radiology. However, fish fed the same diet but
with a normal mineral supply showed a prevalence of 73%
after 1 year in seawater. Other radiological studies on farmed
Atlantic salmon have shown occurrences of vertebral defor-
mities ranging between 3.8 and 20% during the parr stage
(Fjelldal et al., 2007a; Sullivan et al., 2007a,b), between 3.3
and 46% in post smolts (Fjelldal et al., 2009; Wargelius et al.,
2009), and between 12 and 73% in harvest size salmon (Witten
et al., 2006; Fjelldal et al., 2007a, 2009). The 80VP70VL group
had a lower weight gain during the first 3 months of the
experiment compared to the other groups (Torstensen et al.,
2008). This was the first period after transfer to seawater,
(a)
(b)
Fig. 3. Lateral radiograph of deformed vertebral bodies taken at the
end of the experiment in June 2007 from the cranial trunk (V1-8) (a)
and tail fin (V50-58) (b) regions of the vertebral column. The vertebra
number is indicated on the corresponding neural arches. Scale
bar = 1 cm
Fig. 2. Location of vertebral deformities at the end of the experiment
in June 2007. Prevalence (%) of deformed vertebrae in different regions
(R) of the vertebral (V) column in the deformed individuals (all groups
pooled; n = 45). R1 = cranial trunk (V1-8), R2 = caudal trunk (V9-
30), R3 = tail (V31-49), R4 = tail fin (V50-58) (Kacem et al., 1998)
(a)
(b)
Fig. 4. Plasma vitamin D metabolites (25OHD3 and 1,25(OH)2D3;
calcitriol) after 9 months exposure in sea water in salmon fed diets
containing 100% fish protein and lipid (FPFL; here FO) or 80% VP
and 70% VL (80VP70VL; here VO). A part of the tank populations
were transferred to respective opposite diets (crossed-over from FO to
VO and from VO to FO) after 8 months and sampled 27 days after
(i.e. 9 months). n = 9 per dietary group treatment (columns represent
mean values; bars = standard error)
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which in earlier studies has shown to be a critical period for a
normal development of the vertebral column (Fjelldal et al.,
2006, 2007b, 2009). Slower growth in this period may have had
a positive effect on the structural integrity and chemical
composition of the vertebral bodies, and contributed to a more
optimal bone health in the 80VP70VL group.
On the other hand, the results of the present study may also
lead us to speculate if there are some component(s) in marine
feed sources that contributes to the development of vertebral
deformities during on-growth in seawater, irrespective of the
difference in somatic growth. Firstly, substitution of fish oil
with vegetable oil in the feed have shown to reduce the levels of
dioxins and dioxin-like PCBs in farmed Atlantic salmon
(Berntssen et al., 2005), and rainbow trout, (Oncorhynchus
mykiss (Oo et al., 2007). Dioxins are known to interrupt
skeletal development during early life stages in zebra fish
(Danio rerio) (Henry et al., 1997), rainbow trout (Hornug
et al., 1999), Japanese medaka (Oryzias latipes) (Kim and
Cooper, 1999), and fathead minnow (Pimephales promelas)
(Olivieri and Cooper, 1997). However, the impact of dioxins
on bone growth and development at later stages in the life
cycle remains to be studied. Since the 80VP70VL and
40VP70VL dietary groups, both high in vegetable lipids,
developed a prevalence of vertebral deformities at 11 and 40%,
respectively, the presently reported deformities are most
probably not induced by dioxins.
Secondly, marine ingredients are among the few natural
sources of vitamin D, like the classical cod liver oil used as a
natural vitamin D supplement for humans. While vitamin D is
essential to human bone health, the role of the vitamin D
endocrine system in fish bone growth and development is more
uncertain (Lock et al., 2010). For adult salmon reared in
calcium rich seawater, vitamin D has been suggested to play a
role in the phosphorous homeostasis. Recently, we observed
elevated levels of plasma vitamin D metabolites in salmon fed
normal level of mineral supply compared to fish fed extra
dietary mineral supply, where the former fish group developed
considerable higher incidences of bone deformities at later
stages (Fjelldal et al., 2009). Plasma phosphorous, but not
calcium was also lower in the normal mineral supplemented
group. The presently observed elevated plasma 25OHD3 and
higher occurrence of vertebral deformities in salmon fed the
complete marine diet, compared to the vegetable group,
supports the idea that plasma levels of vitamin D metabolites
may be used to predict the risk for bone deformities in Atlantic
salmon.
Elevated or toxic dietary vitamin D has been considered as a
risk factor for bone deformities in fish (Graff et al., 2002a,b),
but since extremely high dietary levels of vitamin D did not
impact bone health in theses studies, it has been suggested that
the risk may be related to the potential active metabolites in
the marine ingredients. The bioavailability of the vitamin D
metabolites from marine sources are not known, and conse-
quently it is difficult to sort out whether the vitamin D
endocrine system is activated by the given conditions (rapid
growth or lack of phosphorous ⁄ mineral supply) or pushed by
elevated dietary intakes and uptakes of vitamin D metabolites
in fish fed the marine diets. However, since the intermediate
replacement groups also developed bone deformities at a
similar incidence as the marine diet (not analysed for vitamin
D metabolites), the former suggestion is most probable.
Interestingly, fish crossed-over from the marine to the high
vegetable diet reduced plasma 25OHD3, while fish crossed
over from vegetable diet to marine diet did not show elevated
plasma 25OHD3. This further supports the idea that the
relationship between D-vitamin metabolites and the develop-
ment of bone deformities acts through an activation of the
vitamin D system.
The location and severity of the deformities
The vertebral column of Atlantic salmon can be sub-divided
into 4 main regions; the cranial trunk (V1 fi 8), caudal trunk
(V9 fi 30), tail (V31 fi 49), and tail fin (V50 fi 58) regions
(Kacem et al., 1998). The vertebrae of the cranial and caudal
trunk regions posses ribs, while the vertebrae of the tail and
tail fin regions posses haemal arches. In the present study, the
predominate locations for vertebral deformities were in the
cranial trunk and tail fin regions of the vertebral column, and
there was a low occurrence of deformities in the tail region,
and intermediate occurrence in the caudal trunk region. This is
in agreement with the findings of Fjelldal et al. (2009), who
found that a group of salmon that had the same occurrences of
vertebral deformities as the FPFL, 80VP35VL and 40VP70VL
diets at the same stages of the production cycle had no
development of deformities in the tail region over time from
seawater transfer until harvest size. On the other hand,
deformities that develop in the cranial and caudal trunk
regions have shown to be present at the parr stage (Fjelldal
et al., 2007a; Sullivan et al., 2007a), while deformities in the
tail and tail fin regions have shown to develop later in
ontogeny (Fjelldal et al., 2007a, 2009), and in some cases after
transfer to seawater. Thus, it is possible that the deformities in
the present study were initiated before the onset of the
experiment, and that the 80VP70VL diet had a therapeutic
effect and reduced the extent of the disorder, maybe through a
reduction in growth rate during the early seawater phase. In
the FPFL, 80VP35VL and 40VP70VL dietary groups, some of
the deformed fish had more than 10 deformed vertebrae. Such
severe cases with more than 10 deformed vertebrae imply
impaired fish welfare, as it will reduce the growth performance
of the fish (Hansen et al., 2010; Fjelldal, P.G., Yurtseva,
A.,Berg, A., 2009, Unpubl. data).
Gene expressional levels
The vertebral gene expression of igf-I was significantly higher
in the fish fed the 80VP70VL diet compared to the fish fed the
FPFL diet. In Atlantic salmon vertebral bone, induction in
gene expression of igf-i and its receptor has been associated
with increased ECM production and increased size of the
vertebrae (Wargelius et al., 2005; Nordgarden et al., 2006).
This may imply that the vertebral bodies of the fish fed the
80VP70VL diet were better equipped for a normal develop-
ment compared to those of the fish fed the FPFL diet. The
vertebral bone gene expression of ghr and igf-I was signif-
icantly higher in July 2006 compared to June 2007 in the FPFL
and 80VP70VL dietary groups, respectively. The weight gain
(% day)1) was 0.88–1.00% in June–September 2006, and 0.35–
0.44% in February–June 2007. Thus, the higher expression of
ghr and igf-I in the early part of the experiment may have been
related to higher growth rate in this period.
Concluding remarks
The combination of high inclusion levels of both vegetable
lipids and proteins had a positive effect on bone health in
Atlantic salmon postsmolts, when compared to lower inclusion
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levels of vegetable lipids or proteins, or a pure marine diet.
This may be related to slower growth during the early seawater
phase in the fish fed the highest inclusion levels.
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